Metraipolis › archive › dc_5f9d13e671bc
What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda — Europe PMC PMID:35587501
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35587501
- DOI
- 10.1371/journal.pone.0268063
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-18T11:18:53.165Z
- SHA-256 of the archived text
505f240e95ac4cdd322781d41e4fadef92d90c541e5415a11c74135b669eaca1- Stable URL of this page
https://metraipolis.com/documento/dc_5f9d13e671bc
How to cite
What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda — Europe PMC PMID:35587501 — Europe PMC (en), https://europepmc.org/article/MED/35587501 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_5f9d13e671bc (Metraipolis archive dc_5f9d13e671bc, sha256 505f240e95ac4cdd322781d41e4fadef92d90c541e5415a11c74135b669eaca1)
BibTeX
@misc{dc5f9d13e671bc,
title = {What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda — Europe PMC PMID:35587501},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35587501},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_5f9d13e671bc; sha256 505f240e95ac4cdd322781d41e4fadef92d90c541e5415a11c74135b669eaca1},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35587501. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: There is a critical need to identify the drivers of willingness to receive new vaccines against emerging and epidemic diseases. A discrete choice experiment is the ideal approach to evaluating how individuals weigh multiple attributes simultaneously. We assessed the degree to which six attributes were associated with willingness to be vaccinated among university students in Uganda. Methods: We conducted a single-profile discrete choice experiment at Makerere University in 2019. Participants were asked whether or not they would be vaccinated in 8 unique scenarios where attributes varied by disease risk, disease severity, advice for or against vaccination from trusted individuals, recommendations from influential figures, whether the vaccine induced indirect protection, and side effects. We calculated predicted probabilities of vaccination willingness using mixed logistic regression models, comparing health professional students with all other disciplines. Findings: Of the 1576 participants, 783 (49.8%) were health professional students and 685 (43.5%) were female. Vaccination willingness was high (78%), and higher among health students than other students. We observed the highest vaccination willingness for the most severe disease outcomes and the greatest exposure risks, along with the Minister of Health's recommendation or a vaccine that extended secondary protection to others. Mild side effects and recommendations against vaccination diminished vaccination willingness. Interpretation: Our results can be used to develop evidence-based messaging to encourage uptake for new vaccines. Future vaccination campaigns, such as for COVID-19 vaccines in development, should consider acknowledging individual risk of exposure and disease severity and incorporate recommendations from key health leaders. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-05-19). Identificativi: PMID 35587501 · PMCID PMC9119467 · DOI 10.1371/journal.pone.0268063. Descrittori MeSH principali: Communicable Diseases, Emerging; Vaccines; COVID-19. Pagina: https://europepmc.org/article/MED/35587501 — https://doi.org/10.1371/journal.pone.0268063. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-18T11:17:42.843Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.